OncoHost Launches PROphet® NSCLC Cancer Test in the United States
Predictive blood test guides first-line treatment decisions for advanced unresectable NSCLC cancer patients.
Predictive blood test guides first-line treatment decisions for advanced unresectable NSCLC cancer patients.